Jundishapur Journal of Microbiology

Published by: Kowsar

An Analysis of the Type and Antimicrobial Resistance of Carbapenemase-Producing Enterobacteriaceae Isolated at the Military Institute of Medicine in Warsaw, Poland, 2009-2016

Aneta Guzek 1 , Zbigniew Rybicki 2 and Dariusz Tomaszewski 2 , *
Authors Information
1 Section of Microbiology, Department of Laboratory Diagnostics, Military Institute of Medicine, Warsaw, Poland
2 Department of Anesthesiology and Intensive Therapy, Military Institute of Medicine, Warsaw, Poland
Article information
  • Jundishapur Journal of Microbiology: 12 (1); e67823
  • Published Online: January 9, 2019
  • Article Type: Research Article
  • Received: February 22, 2018
  • Revised: November 26, 2018
  • Accepted: December 13, 2018
  • DOI: 10.5812/jjm.67823

To Cite: Guzek A, Rybicki Z, Tomaszewski D. An Analysis of the Type and Antimicrobial Resistance of Carbapenemase-Producing Enterobacteriaceae Isolated at the Military Institute of Medicine in Warsaw, Poland, 2009-2016, Jundishapur J Microbiol. Online ahead of Print ; 12(1):e67823. doi: 10.5812/jjm.67823.

Abstract
Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Glasner C, Albiger B, Buist G, Tambic Andrasevic A, Canton R, Carmeli Y, et al. Carbapenemase-producing Enterobacteriaceae in Europe: A survey among national experts from 39 countries, February 2013. Euro Surveill. 2013;18(28). [PubMed: 23870096].
  • 2. European Center for Disease Prevention and Control. rapid risk assessment: Carbapenem-resistant enterobacteriaceae, 14 april 2016. European Center For Disease Prevention And Control; 2016.
  • 3. O'Neill J. Tackling drug-resistant infectionsglobally: Final report and recommendations. Review on antimicrobial resistance. 2016.
  • 4. Palmore TN, Henderson DK. Managing transmission of carbapenem-resistant enterobacteriaceae in healthcare settings: A view from the trenches. Clin Infect Dis. 2013;57(11):1593-9. doi: 10.1093/cid/cit531. [PubMed: 23934166]. [PubMed Central: PMC3888298].
  • 5. Grundmann H, Glasner C, Albiger B, Aanensen DM, Tomlinson CT, Andrasevic AT, et al. Occurrence of carbapenemase-producing klebsiella pneumoniae and escherichia coli in the European survey of carbapenemase-producing enterobacteriaceae (EuSCAPE): A prospective, multinational study. Lancet Infect Dis. 2017;17(2):153-63. doi: 10.1016/S1473-3099(16)30257-2. [PubMed: 27866944].
  • 6. Fiett J, Baraniak A, Izdebski R, Sitkiewicz I, Zabicka D, Meler A, et al. The first NDM metallo-beta-lactamase-producing Enterobacteriaceae isolate in Poland: Evolution of IncFII-type plasmids carrying the bla(NDM-1) gene. Antimicrob Agents Chemother. 2014;58(2):1203-7. doi: 10.1128/AAC.01197-13. [PubMed: 24247128]. [PubMed Central: PMC3910837].
  • 7. Tumbarello M, Trecarichi EM, Tumietto F, Del Bono V, De Rosa FG, Bassetti M, et al. Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2014;58(6):3514-20. doi: 10.1128/AAC.02373-13. [PubMed: 24733460]. [PubMed Central: PMC4068482].
  • 8. Hussein K, Sprecher H, Mashiach T, Oren I, Kassis I, Finkelstein R. Carbapenem resistance among Klebsiella pneumoniae isolates: Risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol. 2009;30(7):666-71. doi: 10.1086/598244. [PubMed: 19496647].
  • 9. Hawkey PM, Warren RE, Livermore DM, McNulty CAM, Enoch DA, Otter JA, et al. Treatment of infections caused by multidrug-resistant Gram-negative bacteria: Report of the British society for antimicrobial chemotherapy/healthcare infection society/British infection association joint working party. J Antimicrob Chemother. 2018;73(suppl_3):iii2-iii78. doi: 10.1093/jac/dky027. [PubMed: 29514274].
  • 10. Rodriguez-Bano J, Gutierrez-Gutierrez B, Machuca I, Pascual A. Treatment of infections caused by extended-spectrum-beta-lactamase-, ampC-, and carbapenemase-producing enterobacteriaceae. Clin Microbiol Rev. 2018;31(2). doi: 10.1128/CMR.00079-17. [PubMed: 29444952]. [PubMed Central: PMC5967687].
  • 11. Glupczynski Y, Huang TD, Bouchahrouf W, Rezende de Castro R, Bauraing C, Gerard M, et al. Rapid emergence and spread of OXA-48-producing carbapenem-resistant enterobacteriaceae isolates in Belgian hospitals. Int J Antimicrob Agents. 2012;39(2):168-72. doi: 10.1016/j.ijantimicag.2011.10.005. [PubMed: 22115539].
  • 12. van Dijk K, Voets GM, Scharringa J, Voskuil S, Fluit AC, Rottier WC, et al. A disc diffusion assay for detection of class A, B and OXA-48 carbapenemases in Enterobacteriaceae using phenyl boronic acid, dipicolinic acid and temocillin. Clin Microbiol Infect. 2014;20(4):345-9. doi: 10.1111/1469-0691.12322. [PubMed: 23927659].
  • 13. Nordmann P, Poirel L, Dortet L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2012;18(9):1503-7. doi: 10.3201/eid1809.120355. [PubMed: 22932472]. [PubMed Central: PMC3437707].
  • 14. Literacka E, Herda M, Baraniak A, Zabicka D, Hryniewicz W, Skoczynska A, et al. Evaluation of the Carba NP test for carbapenemase detection in Enterobacteriaceae, Pseudomonas spp. and Acinetobacter spp., and its practical use in the routine work of a national reference laboratory for susceptibility testing. Eur J Clin Microbiol Infect Dis. 2017;36(11):2281-7. doi: 10.1007/s10096-017-3062-0. [PubMed: 28744664]. [PubMed Central: PMC5653713].
  • 15. Fiett J, Baraniak A, Mrowka A, Fleischer M, Drulis-Kawa Z, Naumiuk L, et al. Molecular epidemiology of acquired-metallo-beta-lactamase-producing bacteria in Poland. Antimicrob Agents Chemother. 2006;50(3):880-6. doi: 10.1128/AAC.50.3.880-886.2006. [PubMed: 16495246]. [PubMed Central: PMC1426447].
  • 16. Papagiannitsis CC, Studentova V, Ruzicka F, Tejkalova R, Hrabak J. Molecular characterization of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a Czech hospital (2009-2011). J Med Microbiol. 2013;62(Pt 6):945-7. doi: 10.1099/jmm.0.056119-0. [PubMed: 23493029].
  • 17. Izdebski R, Bojarska K, Baraniak A, Literacka E, Herda M, Zabicka D, et al. NDM-1- or OXA-48-producing Enterobacteriaceae colonising Polish tourists following a terrorist attack in Tunis, March 2015. Euro Surveill. 2015;20(23). [PubMed: 26084313].
  • 18. Draenert R, Seybold U, Grutzner E, Bogner JR. Novel antibiotics: Are we still in the pre-post-antibiotic era? Infection. 2015;43(2):145-51. doi: 10.1007/s15010-015-0749-y. [PubMed: 25701222]. [PubMed Central: PMC4382537].
  • 19. Poirel L, Kieffer N, Nordmann P. In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother. 2016;71(1):156-61. doi: 10.1093/jac/dkv294. [PubMed: 26416781].
  • 20. Bercot B, Poirel L, Nordmann P. Updated multiplex polymerase chain reaction for detection of 16S rRNA methylases: High prevalence among NDM-1 producers. Diagn Microbiol Infect Dis. 2011;71(4):442-5. doi: 10.1016/j.diagmicrobio.2011.08.016. [PubMed: 22000158].
  • 21. Baraniak A, Izdebski R, Herda M, Fiett J, Hryniewicz W, Gniadkowski M, et al. Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland. Antimicrob Agents Chemother. 2009;53(10):4565-7. doi: 10.1128/AAC.00436-09. [PubMed: 19620323]. [PubMed Central: PMC2764197].
  • 22. European Center for Disease Prevention and Control. Plasmid-mediated colistin resistance in Enterobacteriaceae. European Center for Disease Prevention and Control; 2016.
  • 23. Sandri AM, Landersdorfer CB, Jacob J, Boniatti MM, Dalarosa MG, Falci DR, et al. Population pharmacokinetics of intravenous polymyxin B in critically ill patients: Implications for selection of dosage regimens. Clin Infect Dis. 2013;57(4):524-31. doi: 10.1093/cid/cit334. [PubMed: 23697744].
  • 24. Sader HS, Castanheira M, Flamm RK, Mendes RE, Farrell DJ, Jones RN. Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: Results from the SENTRY surveillance program (2010-2013). Diagn Microbiol Infect Dis. 2015;83(2):183-6. doi: 10.1016/j.diagmicrobio.2015.06.011. [PubMed: 26164275].
  • 25. Bassetti M, Peghin M, Pecori D. The management of multidrug-resistant Enterobacteriaceae. Curr Opin Infect Dis. 2016;29(6):583-94. doi: 10.1097/QCO.0000000000000314. [PubMed: 27584587].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments